Early 2020 saw the world break into what has been described as a "war-like situation": A pandemic, caused by the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), the likes of which majority of the living ...
Jul 1, 2021
2
15
Barely three months ago, the anti-malarial drug that President Donald Trump touted seemed like such a sure bet against COVID-19 that Susanna Naggie had a tough time setting up a national clinical trial comparing it to placebo. ...
Jul 6, 2020
0
6
Seemingly unaffected by the controversy in the global scientific community, Greece has resumed production of chloroquine to treat cases of coronavirus and is conducting clinical trials with a "calm and distant approach", ...
Jun 10, 2020
0
5
Since the World Health Organization declared COVID-19 a Public Health Concern of Global Interest on January 30, more than one million have tested positive for the illness in the United States, and more than 62,000 have died. ...
May 1, 2020
0
10
Swiss pharmaceutical giant Novartis said Monday it would sponsor a clinical trial in the US using hydroxychloroquine to treat patients hospitalised with COVID-19.
Apr 20, 2020
0
3
French pharmaceutical giant Sanofi said Friday it would offer 100 million doses of hydroxychloroquine, a treatment for rheumatoid arthritis and lupus, to governments worldwide if studies show it can safely to be used to ...
Apr 10, 2020
0
3
Scientists at the University of Birmingham have found an anti-malarial drug was effective in treating head and neck cancer in mice.
Sep 25, 2019
0
92
The ability to hear depends on proteins to reach the outer membrane of sensory cells in the inner ear. But in certain types of hereditary hearing loss, mutations in the protein prevent it from reaching these membranes. Using ...
Jun 11, 2019
0
72
Scientists have discovered how a protein within the malaria parasite is essential to its survival as it develops inside a mosquito. They believe their findings identify this protein as a potential new target for drug treatments ...
Apr 25, 2013
0
0
The discovery of a potential new anti-malarial drug by a UT Southwestern Medical Center-led research team has been awarded Project of the Year by Medicines for Malaria Venture (MMV).
Jun 7, 2011
0
0
